首页> 美国卫生研究院文献>Journal of Virology >Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment.
【2h】

Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment.

机译:通过抗E2单克隆抗体治疗α干扰素在Sindbis病毒感染的细胞中的抗病毒活性得以恢复。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pretreatment of AT3 rat prostatic carcinoma cells expressing the inhibitor of apoptosis bcl-2 (AT3-bcl-2 cells) with alpha interferon (IFN-alpha) affected replication of a virulent strain of Sindbis virus (SV) but did not protect against virus-induced cell death. Treatment of cells with IFN-alpha late during infection affected ongoing SV replication very little. Previous studies have shown that cross-linking of the viral glycoprotein E2 with antibody delays the inhibition of K+ influx by improving the function of Na+K+ATPase and the Na(+)-K(+)-2Cl-cotransport system in SV-infected cells (P. Després, J. W. Griffin, and D. E. Griffin, J. Virol. 69:7006-7014, 1995). In these studies, we have shown that treatment of infected cells with anti-E2 monoclonal antibody also restored the ability of IFN-alpha to induce antiviral activity in infected cells late during infection. The very low rate of virus release in SV-infected cells treated simultaneously with anti-E2 monoclonal antibody and IFN-alpha was postulated to be linked to inhibition of virus maturation. Synergistic effects of antibody and IFN-alpha are likely to be important for control of SV replication in vivo.
机译:用α干扰素(IFN-α)预处理表达凋亡抑制因子bcl-2的AT3大鼠前列腺癌细胞(AT3-bcl-2细胞)影响了辛德比斯病毒(SV)毒株的复制,但没有针对病毒-诱导细胞死亡。在感染后期用IFN-α处理细胞对正在进行的SV复制影响很小。先前的研究表明,病毒糖蛋白E2与抗体的交联通过改善SV-中的Na + K + ATPase和Na(+)-K(+)-2Cl-cotransport系统的功能来延迟对K +内流的抑制。感染的细胞(P.Després,JW Griffin,和DE Griffin,J.Virol.69:7006-7014,1995)。在这些研究中,我们显示了用抗E2单克隆抗体处理感染细胞也恢复了IFN-α在感染后期诱导感染细胞中抗病毒活性的能力。假定同时用抗E2单克隆抗体和IFN-α处理的SV感染细胞中病毒的释放速率非常低,这与抑制病毒成熟有关。抗体和IFN-α的协同作用对于体内控制SV复制可能很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号